OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study
Margherita Fabbri, Clémence Leung, Guillaume Baille, et al.
Parkinsonism & Related Disorders (2021) Vol. 89, pp. 128-133
Open Access | Times Cited: 23
Margherita Fabbri, Clémence Leung, Guillaume Baille, et al.
Parkinsonism & Related Disorders (2021) Vol. 89, pp. 128-133
Open Access | Times Cited: 23
Showing 23 citing articles:
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
Edoardo Bianchini, Camilla Onelli, Carmen Morabito, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 31
Edoardo Bianchini, Camilla Onelli, Carmen Morabito, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 31
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
Fabien Zagnoli, A. Leblanc, Irina Viakhireva-Dovganyuk, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1463-1474
Open Access | Times Cited: 12
Fabien Zagnoli, A. Leblanc, Irina Viakhireva-Dovganyuk, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1463-1474
Open Access | Times Cited: 12
The impact of the quarantine period due to the pandemic on the severity of Parkinson's disease and the quality of life of Parkinson's patients
Fatemeh Rafizadeh, Masoud Saadat Fakhr, Elham Davtalab Esmaeili, et al.
Clinics (2025) Vol. 80, pp. 100605-100605
Open Access
Fatemeh Rafizadeh, Masoud Saadat Fakhr, Elham Davtalab Esmaeili, et al.
Clinics (2025) Vol. 80, pp. 100605-100605
Open Access
Parkinson's disease and Covid-19: The effect and use of telemedicine
Aleksandra Podlewska, Daniel J. van Wamelen
International review of neurobiology (2022), pp. 263-281
Open Access | Times Cited: 14
Aleksandra Podlewska, Daniel J. van Wamelen
International review of neurobiology (2022), pp. 263-281
Open Access | Times Cited: 14
A Peek into Pandora’s Box: COVID-19 and Neurodegeneration
Abhishek Chandra, Ashu Johri
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 190-190
Open Access | Times Cited: 11
Abhishek Chandra, Ashu Johri
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 190-190
Open Access | Times Cited: 11
SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review
Tsepo Goerttler, Eun‐Hae Kwon, Michael Fleischer, et al.
Brain Sciences (2022) Vol. 12, Iss. 4, pp. 456-456
Open Access | Times Cited: 10
Tsepo Goerttler, Eun‐Hae Kwon, Michael Fleischer, et al.
Brain Sciences (2022) Vol. 12, Iss. 4, pp. 456-456
Open Access | Times Cited: 10
The Impact of the COVID-19 Pandemic on Informal Caregivers of People With Parkinson’s Disease Residing in the UK: A Qualitative Study
Daniel Rippon, Annette Hand, Lorelle Dismore, et al.
Journal of Geriatric Psychiatry and Neurology (2022) Vol. 36, Iss. 3, pp. 233-245
Open Access | Times Cited: 9
Daniel Rippon, Annette Hand, Lorelle Dismore, et al.
Journal of Geriatric Psychiatry and Neurology (2022) Vol. 36, Iss. 3, pp. 233-245
Open Access | Times Cited: 9
Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study
Andreas Wolff, Bernhard Haller, Antonia F. Demleitner, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 353-353
Open Access | Times Cited: 8
Andreas Wolff, Bernhard Haller, Antonia F. Demleitner, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 353-353
Open Access | Times Cited: 8
The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study
Luca Vignatelli, Flavia Baccari, Laura Maria Beatrice Belotti, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 7
Luca Vignatelli, Flavia Baccari, Laura Maria Beatrice Belotti, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 7
Impact of COVID ‐19 pandemic on patients with Parkinson's disease: A meta‐analysis of 13,878 patients
Aaron Shengting, Jung Hahn Yong, Brendan Jen‐Wei Tan, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1504-1513
Open Access | Times Cited: 7
Aaron Shengting, Jung Hahn Yong, Brendan Jen‐Wei Tan, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1504-1513
Open Access | Times Cited: 7
Clinical and Functional Evolution in Subjects with Parkinson’s Disease during SARS-CoV-2 Pandemic
Marianna Capecci, Nicolò Baldini, Francesca Campignoli, et al.
Applied Sciences (2023) Vol. 13, Iss. 2, pp. 1126-1126
Open Access | Times Cited: 3
Marianna Capecci, Nicolò Baldini, Francesca Campignoli, et al.
Applied Sciences (2023) Vol. 13, Iss. 2, pp. 1126-1126
Open Access | Times Cited: 3
The joint impact of symptom deterioration and social factors on wellbeing for people with Parkinson's during the covid-19 pandemic in the UK
Fiona Eccles, Ian Garner, Craig Murray, et al.
Journal of the Neurological Sciences (2023) Vol. 452, pp. 120768-120768
Closed Access | Times Cited: 3
Fiona Eccles, Ian Garner, Craig Murray, et al.
Journal of the Neurological Sciences (2023) Vol. 452, pp. 120768-120768
Closed Access | Times Cited: 3
Living with Parkinson’s in England during and beyond COVID-19 restrictions: a longitudinal qualitative study
Craig Murray, Fiona Eccles, Ian Garner, et al.
Aging & Mental Health (2023) Vol. 28, Iss. 1, pp. 151-159
Open Access | Times Cited: 3
Craig Murray, Fiona Eccles, Ian Garner, et al.
Aging & Mental Health (2023) Vol. 28, Iss. 1, pp. 151-159
Open Access | Times Cited: 3
Changes in non-motor symptoms in patients with Parkinson's disease following COVID-19 pandemic restrictions: A systematic review
Francesca Mameli, Eleonora Zirone, Benedetta Capetti, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 5
Francesca Mameli, Eleonora Zirone, Benedetta Capetti, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 5
Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review
Sorayya Rezayi, Meysam Rahmani Katigari, Leila Shahmoradi, et al.
Parkinson s Disease (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 2
Sorayya Rezayi, Meysam Rahmani Katigari, Leila Shahmoradi, et al.
Parkinson s Disease (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 2
Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
Conor Fearon, Alfonso Fasano
International review of neurobiology (2022), pp. 35-62
Open Access | Times Cited: 4
Conor Fearon, Alfonso Fasano
International review of neurobiology (2022), pp. 35-62
Open Access | Times Cited: 4
Movement Disorders andSARS‐CoV ‐2
Wilson Fung, Alfonso Fasano, Conor Fearon
Movement Disorders Clinical Practice (2022) Vol. 10, Iss. S2
Open Access | Times Cited: 3
Wilson Fung, Alfonso Fasano, Conor Fearon
Movement Disorders Clinical Practice (2022) Vol. 10, Iss. S2
Open Access | Times Cited: 3
Psychological Impact of COVID-19 on individuals: Through Active Choices and Passive Adaption
Jianchun Fang, Chi Keung Marco Lau, Yan Cheng
Frontiers research topics (2024)
Open Access
Jianchun Fang, Chi Keung Marco Lau, Yan Cheng
Frontiers research topics (2024)
Open Access
Long‐Lasting Impact of the COVID ‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives
Andreas Wolff, Bernhard Haller, Antonia F. Demleitner, et al.
Movement Disorders Clinical Practice (2023) Vol. 10, Iss. 5, pp. 819-823
Open Access | Times Cited: 1
Andreas Wolff, Bernhard Haller, Antonia F. Demleitner, et al.
Movement Disorders Clinical Practice (2023) Vol. 10, Iss. 5, pp. 819-823
Open Access | Times Cited: 1
Spotlight on non-motor symptoms and Covid-19
Silvia Rota, Iro Boura, Yi Min Wan, et al.
International review of neurobiology (2022), pp. 103-133
Open Access | Times Cited: 2
Silvia Rota, Iro Boura, Yi Min Wan, et al.
International review of neurobiology (2022), pp. 103-133
Open Access | Times Cited: 2
Parkinson’s Disease and the COVID-19 Pandemic: Do Quarantine Affect the Motor and Non-Motor Symptoms of Patients with and without Deep Brain Stimulation?
Nesrin Helvaci Yilmaz, Basak Bolluk Kılıç, T. Ali Zirh, et al.
Medical Bulletin of Haseki (2022) Vol. 60, Iss. 3, pp. 204-210
Open Access | Times Cited: 1
Nesrin Helvaci Yilmaz, Basak Bolluk Kılıç, T. Ali Zirh, et al.
Medical Bulletin of Haseki (2022) Vol. 60, Iss. 3, pp. 204-210
Open Access | Times Cited: 1
Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
Rodrigo León-García, Emmanuel Ortega-Robles, Óscar Arias-Carrión
Brain Sciences (2023) Vol. 13, Iss. 7, pp. 1114-1114
Open Access
Rodrigo León-García, Emmanuel Ortega-Robles, Óscar Arias-Carrión
Brain Sciences (2023) Vol. 13, Iss. 7, pp. 1114-1114
Open Access
Telemedicine and digital health solutions for managing movement disorders emergencies
Larisa Ungureanu, Rafaela Filip, Bogdan Ciopleiaș, et al.
International review of movement disorders (2023), pp. 217-241
Closed Access
Larisa Ungureanu, Rafaela Filip, Bogdan Ciopleiaș, et al.
International review of movement disorders (2023), pp. 217-241
Closed Access
National cross-sectional survey on psychological impact on French nursing homes of the first lockdown during the COVID-19 pandemic as observed by psychologists, psychomotor, and occupational therapists
Anne-Julie Vaillant-Ciszewicz, Bérengère Couturier, Lauriane Segaux, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
Anne-Julie Vaillant-Ciszewicz, Bérengère Couturier, Lauriane Segaux, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
